<DOC>
	<DOC>NCT00406432</DOC>
	<brief_summary>The study was designed to assess the steady-state pharmacokinetic profile of paroxetine after 14 day repeated daily dosing of the controlled release tablet formulation (25 mg) in healthy Chinese subjects.</brief_summary>
	<brief_title>A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Inclusion criteria: 1945 years healthy Chinese subjects Body weight &gt; 50 kg BMI between 1925 serological negative for HIV, syphilis and hepatitis B and C no abnormalities in ECG Female with negative pregnancy and male has no plan to have a child during and 3 months after the study. Exclusion criteria: History of chronic physical/mental disease, current disease and concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>BRL029060/Paroxetine CR</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>repeat dose</keyword>
</DOC>